ConductScience.org, home

Gene · 859

CAV3: caveolin 3

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CAV3: caveolin 3. Genes, record 859. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/859

On this page

Gene

Symbol
CAV3
HGNC
Name
caveolin 3
HGNC
NCBI Gene ID
859
NCBI Gene
HGNC ID
HGNC:1529
HGNC
Ensembl
ENSG00000182533
NCBI Gene
Aliases
LGMD1C, LQT9, MPDT, RMD2, VIP-21, VIP21
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P56539Caveolin-31510Ensembl, GeneID, HGNC

Source UniProt

Patents45

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440357P56539Espacenet
JP 2026004568 A2026-01-1440358P56539Espacenet
JP 2025529142 A2025-09-04744P56539Espacenet
US 12371689 B22025-07-29744P56539Espacenet
US 11446398 B22022-09-2012649P56539Espacenet
US 11446398 B22022-09-2012650P56539Espacenet
US 11400116 B22022-08-022321P56539Espacenet
US 11400116 B22022-08-025489P56539Espacenet
JP 2022524081 A2022-04-27115620P56539Espacenet
JP 2022524081 A2022-04-27115621P56539Espacenet

1 to 10 of 45

See all 45 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,674

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCAV3 papersNewest fiscal year
I01BX001963Molecular Regulators of Mitochondria in Diabetic Cardiomyopathy182025
R01HL141214Functional Microdomains in the Heart's Pacemaker: A New Dimension of Cardiac Remodeling82025
P30CA056036Translational Research in Cancer52025
P30CA068485Cancer Center Support Grant52025
R01HL131517Sex-specific arrhythmogenic mechanisms of atrial fibrillation52025
T32HL007936Training Program in Translational Cardiovascular Science52025
ZIANS003129Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies52025
P30EY008126Core Grant in Vision Research42025
R01NS055251Voltage-Gated Calcium Channels in Nociceptors and Mechanoreceptors42025
P30DK058404Molecular and Cellular Basis for Digestive Diseases32025

1 to 10 of 1,674Source NIH's project files

See all 1,674 nih grants

Papers2,790

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Patient-Derived iPSC-Cardiomyocytes Reveal Subclinical Cardiomyocyte Dysfunction Associated With the CAV3 N-Terminal Variant p.Ala46Thr.Hum Mutat202642774892PubTator, text miningPubMed
Identification of a novel signature for prognostic stratification and integrative analyses in lung adenocarcinoma.Transl Cancer Res202642724475PubTator, text miningPubMed
Dysfunction of caveolae in muscle disease: A cell biological perspective.J Cell Biol202642714334PubTator, text miningPubMed
The expanding role of Cav3 channels in glioblastoma.Trends Pharmacol Sci202642697770PubTator, text miningPubMed
Case Report: Anti-cavin-4-positive immune-mediated rippling muscle disease co-occurring with isolated ocular myasthenia gravis.Front Immunol202642620730PubTator, text miningPubMed
Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation.Circ Res202642594169PubTator, text miningPubMed
Coordinated Transcriptional Repression of CAV1 and CAV2 in Thoracic Aortic Aneurysm: A microRNA Regulatory Network Analysis.Genes (Basel)202642510867PubTator, text miningPubMed
Rippling muscle disease due to a CAV3 mutation with myocarditis-like presentation in an adolescent.Turk J Pediatr202642497437PubTator, text miningPubMed
Aging Disrupts L-type Ca2+ Channel Organization and Function in Pacemaker Cells.Circ Res202642318626PubTator, text miningPubMed
Proteomic insights into azoospermia: protein differences in testicular tissue between non-obstructive and obstructive azoospermia patients.Asian J Androl202642210639PubTator, text miningPubMed

1 to 10 of 2,790

See all 2,790 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/859

GET https://conductscience.org/api/genes/v1/859/patents?page=2